Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Binder

Showing results (191-200 of 219) with videos related to

Pageof 22
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha2-antiplasmin complex is an independent predictor of coronary re-eventsM Redondo, V A Carroll, T Mauron, et al.
The Journal of Biological Chemistry|January 22, 2001
Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissueI Korschineck, S Ziegler, J Breuss, et al.
Thrombosis and Haemostasis|May 11, 1999
Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patientsM Gottsauner-Wolf, H Sochor, S Hornykewycz, et al.
Circulation|October 1, 1992
Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertensionM A Olman, J J Marsh, I M Lang, et al.
Thrombosis and Haemostasis|June 1, 2002
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cellsP Valent, M Baghestanian, H C Bankl, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase EnhancementM P de Maat, G Dooijewaard, P Meijer, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medicationG Christ, M Nikfardjam, R Huber-Beckmann, et al.
Immunopharmacology|May 1, 1996
Protein C inhibitor (PCI)M Geiger, M Zechmeister-Machhart, P Uhrin, et al.
Cytometry|July 13, 2001
Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancerE Plas, V A Carroll, R Jilch, et al.
Blood|August 10, 1999
Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytesM J Prendes, E Bielek, M Zechmeister-Machhart, et al.
Pageof 22

Showing results (191-200 of 219) with videos related to

Sort By:
Pageof 22
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 7, 2001
Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha2-antiplasmin complex is an independent predictor of coronary re-eventsM Redondo, V A Carroll, T Mauron, et al.
The Journal of Biological Chemistry|January 22, 2001
Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissueI Korschineck, S Ziegler, J Breuss, et al.
Thrombosis and Haemostasis|May 11, 1999
Predictive value of PAI-1 plasma activity and thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patientsM Gottsauner-Wolf, H Sochor, S Hornykewycz, et al.
Circulation|October 1, 1992
Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertensionM A Olman, J J Marsh, I M Lang, et al.
Thrombosis and Haemostasis|June 1, 2002
New aspects in thrombosis research: possible role of mast cells as profibrinolytic and antithrombotic cellsP Valent, M Baghestanian, H C Bankl, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase EnhancementM P de Maat, G Dooijewaard, P Meijer, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2005
Predictive value of plasma plasminogen activator inhibitor-1 for coronary restenosis: dependence on stent implantation and antithrombotic medicationG Christ, M Nikfardjam, R Huber-Beckmann, et al.
Immunopharmacology|May 1, 1996
Protein C inhibitor (PCI)M Geiger, M Zechmeister-Machhart, P Uhrin, et al.
Cytometry|July 13, 2001
Variations of components of the plasminogen activation system with the cell cycle in benign prostate tissue and prostate cancerE Plas, V A Carroll, R Jilch, et al.
Blood|August 10, 1999
Synthesis and ultrastructural localization of protein C inhibitor in human platelets and megakaryocytesM J Prendes, E Bielek, M Zechmeister-Machhart, et al.
Pageof 22